Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PI4KIIIbeta-IN-9 is a potent inhibitor of PI4KIIIβ(IC50 of 7 nM). .
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 89.00 | |
5 mg | In stock | $ 247.00 | |
10 mg | In stock | $ 369.00 | |
25 mg | In stock | $ 622.00 | |
50 mg | In stock | $ 885.00 | |
100 mg | In stock | $ 1,190.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 297.00 |
Description | PI4KIIIbeta-IN-9 is a potent inhibitor of PI4KIIIβ(IC50 of 7 nM). . |
Targets&IC50 | PI3Kγ:1046 nM, PI4KIIIα:2.6 μM, PI4KIIIβ:7 nM, PI3Kα:2 μM, PI3KC2γ:1 μM, PI3Kδ:152 nM |
In vitro | PI4KIIIbeta-IN-9 (Compound 9) shows weak inhibition of PI3KC2γ (IC50 ~1 μM), PI3Kα (~2 μM), and PI4KIIIα (~2.6 μM) and <50% inhibition at concentrations up to 20 μM for PI4K2α, PI4K2β, and PI3Kβ. PI4KIIIbeta-IN-9 forms a crescent shape that conforms to the active site of PI4KIIIβ. This molecule makes extensive contacts with PI4KIIIβ.PI4KIIIbeta-IN-9 also inhibits PI3Kδ and PI3Kγ with IC50s of 152 nM and 1046 nM, respectively. |
Molecular Weight | 487.59 |
Formula | C23H25N3O5S2 |
CAS No. | 1429624-84-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 4.88 mg/mL (10 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
PI4KIIIbeta-IN-9 1429624-84-9 PI3K/Akt/mTOR signaling PI4K PI3K PI4 kinases inhibit Inhibitor Phosphatidylinositol 4 kinases PI4KIIIbetaIN9 PI4KIIIb-IN-9 Phosphoinositide 3-kinase PI4KIIIβ-IN-9 PI-4KIIIbeta-IN-9 PI4KIIIbeta IN 9 inhibitor